Clearline Capital LP Sio Gene Therapies Inc. Transaction History

Clearline Capital LP

  • $3.49 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.28 - $0.44 $39,946 - $62,773
-142,667 Reduced 36.33%
250,024 $110,000
Q1 2022

May 16, 2022
BUY
$0.55 - $1.47 $95,801 - $256,051
174,185 Added 79.72%
392,691 $263,000
Q4 2021

Feb 14, 2022
BUY
$1.29 - $2.36 $281,872 - $515,674
218,506 New
218,506 $282,000

Others Institutions Holding SIOX

# of Institutions
2
Shares Held
147K
Call Options Held
0
Put Options Held
0
View Full List

About Sio Gene Therapies Inc.

SIOX Quotes by TradingView
  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email